VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN)

VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) was reported 88 times

VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VACCINATION SITE ULCER 1 0.1429
1 VACCINATION SITE VESICLES 1 0.0455
2 VACCINATION SITE INDURATION 1 0.0294
3 VACCINATION SITE PRURITUS 1 0.0196
4 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 3 0.0089
5 BODY HEIGHT BELOW NORMAL 3 0.0047
6 VACCINATION SITE ERYTHEMA 1 0.0046
7 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 2 0.0044
8 PACKAGING DESIGN ISSUE 1 0.0030
9 INJECTION SITE PUSTULE 1 0.0026
10 BONE DENSITY INCREASED 1 0.0025
11 DRY GANGRENE 1 0.0016
12 ENTEROCOCCAL SEPSIS 1 0.0012
13 JUVENILE IDIOPATHIC ARTHRITIS 3 0.0012
14 ANTIBODY TEST POSITIVE 2 0.0012
15 PRODUCT RECONSTITUTION QUALITY ISSUE 1 0.0011
16 PERIRECTAL ABSCESS 1 0.0009
17 GRAFT VERSUS HOST DISEASE 6 0.0008
18 LYMPHADENITIS 2 0.0008
19 DRUG SPECIFIC ANTIBODY 1 0.0007
20 SUPERINFECTION 1 0.0007
21 INHIBITORY DRUG INTERACTION 1 0.0006
22 PSEUDOMONAL SEPSIS 1 0.0006
23 POLYARTHRITIS 3 0.0006
24 CLOSTRIDIAL INFECTION 1 0.0003
25 RED BLOOD CELL SEDIMENTATION RATE INCREASED 3 0.0003
26 HAEMOLYSIS 2 0.0003
27 ADRENAL INSUFFICIENCY 3 0.0002
28 LEG AMPUTATION 1 0.0002
29 WHEELCHAIR USER 1 0.0002
30 OBESITY 3 0.0002
31 PRODUCT LABEL CONFUSION 1 0.0002
32 SYNOVITIS 3 0.0002
33 PNEUMONIA ASPIRATION 4 0.0002
34 JOINT EFFUSION 1 0.0001
35 SEPTIC SHOCK 6 0.0001
36 MALNUTRITION 1 0.0001
37 COMA 4 0.0001
38 C-REACTIVE PROTEIN INCREASED 3 0.0001
39 CYTOPENIA 1 0.0001
40 OFF LABEL USE 68 0.0001
41 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
42 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
43 PULMONARY MASS 1 0.0001
44 ACUTE MYELOID LEUKAEMIA 1 0.0001
45 BONE DENSITY DECREASED 2 0.0001
46 PRODUCT USE COMPLAINT 1 0.0001
47 IMPAIRED HEALING 2 0.0001
48 DRUG LEVEL INCREASED 1 0.0001
49 MULTI-ORGAN FAILURE 1 0.0001
50 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
51 JOINT INJURY 1 0.0000
52 INFUSION RELATED REACTION 3 0.0000
53 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
54 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
55 ARTHRITIS 3 0.0000
56 SKIN LESION 1 0.0000
57 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
58 HEPATIC FAILURE 1 0.0000
59 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
60 DRUG INTOLERANCE 3 0.0000
61 STAPHYLOCOCCAL INFECTION 1 0.0000
62 HEPATIC ENZYME INCREASED 2 0.0000
63 MOBILITY DECREASED 2 0.0000
64 CARDIO-RESPIRATORY ARREST 1 0.0000
65 PSORIASIS 3 0.0000
66 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
67 MIGRAINE 2 0.0000
68 LEUKOPENIA 1 0.0000
69 SOMNOLENCE 4 0.0000
70 ARTHROPATHY 1 0.0000
71 PANCYTOPENIA 1 0.0000
72 BONE PAIN 1 0.0000
73 FEBRILE NEUTROPENIA 1 0.0000
74 NEUTROPENIA 2 0.0000
75 RESPIRATORY FAILURE 1 0.0000
76 TREATMENT FAILURE 1 0.0000
77 CONDITION AGGRAVATED 3 0.0000
78 CONSTIPATION 2 0.0000
79 SEPSIS 1 0.0000
80 DISEASE PROGRESSION 1 0.0000
81 ACUTE KIDNEY INJURY 1 0.0000
82 VOMITING 3 0.0000
83 NAUSEA 5 0.0000
84 DRUG INTERACTION 1 0.0000
85 MYALGIA 1 0.0000
86 URINARY TRACT INFECTION 1 0.0000
87 DIARRHOEA 3 0.0000
88 DRUG INEFFECTIVE 6 0.0000
89 DECREASED APPETITE 1 0.0000
90 DIZZINESS 2 0.0000
91 PAIN IN EXTREMITY 1 0.0000
92 PYREXIA 1 0.0000
93 PRURITUS 1 0.0000
94 HEADACHE 1 0.0000
95 FATIGUE 1 0.0000